Glucose Tolerance in Healthy Overweight Adults

Completed · Phase 2

Conditions studied: Overweight

In brief

The primary objective is to compare the postprandial glycemic response of healthy overweight adults after consuming an amino acid drink mix versus a control drink.

Key facts

Study ID

NCT00974831

Run by

Abbott Nutrition

People needed

24

Starts

2009-07-01

Expected to finish

2009-10-01

Last updated by the study team

2010-11-25

Who can join

Age: 20 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Fasting blood glucose level of ≥ 70mg/dL and ≤ 125 mg/dL.
• Subject states that he/she does not have type 1 or 2 diabetes.
• Subject is overweight as defined as waist circumference ≥ 101 cm (40 inches) male; ≥ 88 cm (35 inches) female.
• Subject's BMI is ≥ 25 kg/m2.
• Subject's blood pressure is < 140 mm Hg systolic and < 90 mm Hg diastolic.
• Subject is between 20 and 45 years of age, inclusive.
• Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit.
• If female is of childbearing potential, is practicing birth control
• If subject is on a chronic medication such as a thyroid medication or hormone therapy, has been on constant dosage for at least two months prior to screening visit.

You may not qualify if…

• Subject is eating a low carbohydrate diet such as Atkins, Zone, or South Beach diet plan.
• Subject states that he/she has current infection, has had inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks prior to screening visit.
• Subject states that he/she has an active malignancy.
• Subject states that he/she has had a significant cardiovascular event ≤ six months prior to screening visit; or stated history of congestive heart failure.
• Subject states that he/she has end-stage organ failure or is status post organ transplant.
• Subject states that he/she has a history of renal disease.
• Subject states that he/she has current hepatic disease.
• Subject states that he/she has a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
• Subject has taken/is currently taking any herbals, dietary supplements, or medications during the past four weeks prior to screening visit that could profoundly affect blood glucose.
• Subject has taken/is currently taking any herbals, dietary supplements, or medications during the past four weeks prior to screening visit to control hypertension or cholesterol.
• Subject states that he/she has clotting or bleeding disorders.

Where it is running

• University of Texas — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.